OQS
MGNX icon

Occudo Quantitative Strategies’s MacroGenics MGNX Stock Holding History

Occudo Quantitative Strategies’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-82,980
Closed -$287K – 1210
2022
Q3 		$287K Sell
82,980
-64,888
-44% -$248K 0.02% 859
2022
Q2 		$436K Buy
147,868
+120,586
+442% +$634K 0.04% 665
2022
Q1 		$240K Buy
+27,282
New +$301K 0.02% 891

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Occudo Quantitative Strategies's MGNX Position: Q4 2022 in Review

Occudo Quantitative Strategies sold out of MacroGenics (MGNX) in Q4 2022, closing a stake of 82,980 shares — an estimated $287K sold.

Occudo Quantitative Strategies first reported a position in MGNX in Q1 2022 and held it in 3 quarters. The position peaked at $436K in Q2 2022. 135 funds tracked by Wall St. Rank hold MGNX as of Q4 2022.

  • Occudo Quantitative Strategies reported no remaining MacroGenics position as of Q4 2022 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 82,980 MacroGenics shares in Q4 2022, an estimated $287K.
  • Occudo Quantitative Strategies first reported a position in MacroGenics in Q1 2022 and held it in 3 quarters.
  • Occudo Quantitative Strategies's MacroGenics position peaked at $436K in Q2 2022.
  • 135 funds tracked by Wall St. Rank held MacroGenics as of Q4 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.